TITLE

Chronic kidney disease: The distribution of health care dollars

AUTHOR(S)
St. Peter, Wendy L.; Khan, Samina S.; Ebben, James P.; Pereira, Brian J. G.; Collins, Allan J.
PUB. DATE
July 2004
SOURCE
Kidney International;Jul2004, Vol. 66 Issue 1, p313
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Chronic kidney disease: The distribution of health care dollars. Background. The cost of care for end-stage renal disease (ESRD) is known to be high. The factors responsible for higher ESRD cost develop during chronic kidney disease (CKD), where the data on distribution of cost are limited. Methods. This retrospective cohort study of 1995 through 1998 incident dialysis patients was performed to study the distribution of costs during the 24 months prior to initiation of dialysis. Patient data were obtained from the Centers for Medicare and Medicaid Services (CMS). Patients who were Medicare eligible for at least 2 years prior to initiation of dialysis were included in the study. Financial data were obtained from Medicare Part A and Part B claims and inflationary adjustments were made. The study period was divided into four segments based on overall distribution of cost. Results. The mean age was 75 years, 51% were males, 73% were white, and 22% were black. Overall, patient comorbidity increased significantly during the study years. Cost showed a sharp increase in the last 6 months prior to initiation of dialysis. Hospitalization was the major component of cost throughout study period. Patients who initiated hemodialysis incurred a higher cost compared to patients who initiated other modes of kidney replacement therapy. Patients with diabetes or cardiovascular disease incurred higher cost compared to those who had no diabetes or cardiovascular disease, respectively. Conclusion. These data showed that hospitalization was the major component of the sharp increase in cost around the initiation of dialysis. Increased comorbidity was associated with higher cost. A focus on timely management of CKD may prevent future morbidity and costs.
ACCESSION #
13347226

 

Related Articles

  • Comparative Cost-Benefit Analyses of Paricalcitol and Calcitriol in Stage 4 Chronic Kidney Disease from the Perspective of a Health Plan. Gal-Moscovici, Anca; Sprague, Stuart M. // Clinical Drug Investigation;2007, Vol. 27 Issue 2, p105 

    BACKGROUND AND OBJECTIVE: Substantial data for the relative costs of hospitalisation in paricalcitol- and calcitriol-treated patients with chronic kidney disease stage 4 do not exist. The objective of this study was to compare the cost benefit of paricalcitol and calcitriol therapies in chronic...

  • Increased hospitalizations and death in patients with ESRD secondary to lupus. Sule, S; Fivush, B; Neu, A; Furth, S // Lupus;Oct2012, Vol. 21 Issue 11, p1208 

    Background: Systemic lupus erythematosus (SLE) is an autoimmune disease that can affect almost any organ system, including the kidneys. Using a large national dataset, our goal was to compare the morbidity as measured by hospitalization and mortality rates between hemodialysis patients with...

  • Who Should Be Paying for Vitamin D Analogues -- Medicare or the Patients? Hall, Gayle; Grotegut, Jennifer; Rabetoy, Christy Price // Nephrology Nursing Journal;May/Jun2006, Vol. 33 Issue 3, p345 

    Focuses on controversies involving the Medicare coverage for the payment of Vitamin D analogues of patients with chronic kidney disease. Advantages of injectable Vitamin D analogues; Information on least costly alternatives for vitamin D analogues for patients on hemodialysis; Problems with...

  • Assessment of management and treatment responses in haemodialysis patients from Tehran province, Iran. Mitra Mahdavi-Mazdeh; Mahnaz Zamyadi; Mohsen Nafar // Nephrology Dialysis Transplantation;Jan2008, Vol. 23 Issue 1, p288 

    Background. Chronic kidney disease (CKD) and end-stage renal disease (ESRD) are emerging as globally important public health problems, and will necessitate improvements in health-care policy. ESRD incidence/prevalence data are not available from large parts of the developing world. The main...

  • Recovery of Renal Function among ESRD Patients in the US Medicare Program. Mohan, Sumit; Huff, Edwin; Wish, Jay; Lilly, Michael; Chen, Shu-Cheng; McClellan, William M. // PLoS ONE;Dec2013, Vol. 8 Issue 12, p1 

    Background:Patients started on long term hemodialysis have typically had low rates of reported renal recovery with recent estimates ranging from 0.9–2.4% while higher rates of recovery have been reported in cohorts with higher percentages of patients with acute renal failure requiring...

  • Depression as a predictor of mortality and hospitalization among hemodialysis patients in the United States and Europe. Lopes, Antonio Alberto; Bragg, Jennifer; Young, Eric; Goodkin, David; Mapes, Donna; Combe, Christian; Piera, Luis; Held, Philip; Gillespie, Brenda; Port, Friedrich K. // Kidney International;Jul2002, Vol. 62 Issue 1, p199 

    Depression as a predictor of mortality and hospitalization among hemodialysis patients in the United States and Europe. Background. Depression is not uncommon among patients with end-stage renal disease (ESRD) being treated by hemodialysis. We investigated whether risk of mortality and rate of...

  • Interdisciplinary care clinics in chronic kidney disease. Johns, Tanya S.; Yee, Jerry; Smith-Jules, Terrian; Campbell, Ruth C.; Bauer, Carolyn // BMC Nephrology;10/12/2015, Vol. 15, p1 

    The burden of chronic kidney disease (CKD) is substantial, and is associated with high hospitalization rates, premature deaths, and considerable health care costs. These factors provide strong rationale for quality improvement initiatives in CKD care. The interdisciplinary care clinic (IDC) has...

  • CKD key driver of healthcare costs in COPD.  // PharmacoEconomics & Outcomes News;Feb2015, Vol. 722 Issue 1, p8 

    The article reports on the research indicating the role of chronic kidney failure (CKD) in driving significant cost of medical care in patients with chronic obstructive pulmonary disease (COPD).

  • Assessment and significance of abdominal aortic calcification in chronic kidney disease. Hanada, Shigeru; Ando, Ryoichi; Naito, Shotaro; Kobayashi, Namiko; Wakabayashi, Mai; Hata, Toshihiko; Sasaki, Sei // Nephrology Dialysis Transplantation;Jun2010, Vol. 25 Issue 6, p1888 

    Background. Abdominal aortic calcification is a common complication and a predictor of cardiovascular mortality in dialysis patients. However, abdominal aortic calcification in pre-dialysis chronic kidney disease (CKD) is poorly understood.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics